Pinnacle Associates LTD Eli Lilly & CO Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Pinnacle Associates LTD holds 58,295 shares of LLY stock, worth $45.4 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

58,295

Previous 57,016 2.24%

Holding current value

$45.4 Million

Previous $51.6 Million 0.05%

% of portfolio

0.82%

Previous 0.83%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $987,567 - $1.23 Million	1,279 Added 2.24%	58,295 $51.6 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $295,746 - $370,888	-408 Reduced 0.71%	57,016 $51.6 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $515,806 - $690,075	-871 Reduced 1.49%	57,424 $44.7 Million
Q4 2023 Jan 19, 2024	SELL	$525.19 - $619.13 $2.33 Million - $2.75 Million	-4,438 Reduced 7.07%	58,295 $34 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $785,502 - $1.08 Million	-1,807 Reduced 2.8%	62,733 $33.7 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $1.81 Million - $2.41 Million	5,149 Added 8.67%	64,540 $30.3 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $161,527 - $189,706	-520 Reduced 0.87%	59,391 $20.4 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $6,109 - $7,118	-19 Reduced 0.03%	59,911 $21.9 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $560,783 - $653,424	-1,744 Reduced 2.83%	59,930 $0
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $529,216 - $603,097	-1,785 Reduced 2.81%	61,674 $19.9 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $138,807 - $162,980	-498 Reduced 0.78%	63,459 $20.6 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $184,466 - $229,244	786 Added 1.24%	63,957 $18.3 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $108,602 - $134,776	483 Added 0.77%	63,171 $17.4 Million
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $63,820 - $78,540	-288 Reduced 0.46%	62,688 $14.5 Million
Q2 2021 Aug 02, 2021	BUY	$180.55 - $233.54 $4.15 Million - $5.37 Million	22,986 Added 57.48%	62,976 $14.5 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $588,922 - $762,388	-3,584 Reduced 8.23%	39,990 $7.47 Million
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $25,178 - $33,317	-193 Reduced 0.44%	43,574 $7.36 Million
Q3 2020 Oct 23, 2020	SELL	$146.22 - $169.13 $210,849 - $243,885	-1,442 Reduced 3.19%	43,767 $6.48 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $124,551 - $149,896	-913 Reduced 1.98%	45,209 $7.42 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $23,690 - $29,322	-199 Reduced 0.43%	46,122 $6.4 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $14,434 - $17,878	135 Added 0.29%	46,321 $6.09 Million
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $142,457 - $154,957	1,334 Added 2.97%	46,186 $5.17 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $507,972 - $592,932	-4,585 Reduced 9.27%	44,852 $4.97 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $335,933 - $395,418	-3,018 Reduced 5.75%	49,437 $6.42 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $169,651 - $190,061	-1,602 Reduced 2.96%	52,455 $6.07 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $41,642 - $52,045	485 Added 0.91%	54,057 $5.8 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $36,790 - $42,223	-486 Reduced 0.9%	53,572 $4.57 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $55,063 - $64,999	742 Added 1.39%	54,058 $4.18 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $28,433 - $30,497	347 Added 0.66%	53,316 $4.5 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $127,088 - $141,055	1,649 Added 3.21%	52,969 $4.53 Million
Q2 2017 Aug 09, 2017	BUY	N/A	51,320	51,320 $4.22 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Eli Lilly & CO Transaction History